Free Trial

BioLife Solutions (BLFS) Competitors

BioLife Solutions logo
$26.40 -0.12 (-0.45%)
As of 12:14 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BLFS vs. GKOS, TMDX, SLNO, NVST, LIVN, WRBY, INSP, EYE, PRCT, and AORT

Should you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), National Vision (EYE), PROCEPT BioRobotics (PRCT), and Artivion (AORT). These companies are all part of the "medical equipment" industry.

BioLife Solutions vs. Its Competitors

Glaukos (NYSE:GKOS) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Glaukos has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.95, suggesting that its share price is 95% more volatile than the S&P 500.

BioLife Solutions has lower revenue, but higher earnings than Glaukos. BioLife Solutions is trading at a lower price-to-earnings ratio than Glaukos, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Glaukos$383.48M12.65-$146.37M-$1.65-51.26
BioLife Solutions$82.25M15.37-$20.18M-$0.12-220.00

BioLife Solutions has a net margin of -5.39% compared to Glaukos' net margin of -21.43%. BioLife Solutions' return on equity of 0.16% beat Glaukos' return on equity.

Company Net Margins Return on Equity Return on Assets
Glaukos-21.43% -8.59% -6.61%
BioLife Solutions -5.39%0.16%0.14%

In the previous week, Glaukos had 4 more articles in the media than BioLife Solutions. MarketBeat recorded 8 mentions for Glaukos and 4 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 1.07 beat Glaukos' score of 0.67 indicating that BioLife Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Glaukos
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
BioLife Solutions
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

99.0% of Glaukos shares are owned by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are owned by institutional investors. 6.4% of Glaukos shares are owned by company insiders. Comparatively, 2.2% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Glaukos presently has a consensus target price of $122.00, indicating a potential upside of 44.23%. BioLife Solutions has a consensus target price of $31.29, indicating a potential upside of 18.51%. Given Glaukos' higher possible upside, equities analysts clearly believe Glaukos is more favorable than BioLife Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Glaukos
2 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.69
BioLife Solutions
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.89

Summary

BioLife Solutions beats Glaukos on 9 of the 16 factors compared between the two stocks.

Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLFS vs. The Competition

MetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.26B$10.71B$6.13B$10.51B
Dividend YieldN/A1.86%5.51%4.67%
P/E Ratio-219.9722.2285.5226.80
Price / Sales15.3727.52585.10183.02
Price / Cash217.0425.6126.3031.10
Price / Book3.513.4613.166.63
Net Income-$20.18M$210.63M$3.30B$276.44M
7 Day Performance3.49%1.82%4.71%2.93%
1 Month Performance-0.23%1.40%8.36%9.95%
1 Year Performance10.23%-5.70%87.42%39.62%

BioLife Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLFS
BioLife Solutions
2.663 of 5 stars
$26.40
-0.5%
$31.29
+18.5%
+8.1%$1.26B$82.25M-219.97440Positive News
GKOS
Glaukos
4.5087 of 5 stars
$81.24
+1.7%
$123.58
+52.1%
-33.9%$4.58B$383.48M-49.24780
TMDX
TransMedics Group
3.1373 of 5 stars
$112.64
-1.1%
$125.40
+11.3%
-18.0%$3.88B$441.54M58.36210Positive News
SLNO
Soleno Therapeutics
4.1779 of 5 stars
$68.16
+4.9%
$115.09
+68.9%
+17.8%$3.45BN/A-16.4630Analyst Forecast
NVST
Envista
3.7019 of 5 stars
$20.22
-0.7%
$20.92
+3.5%
+9.6%$3.38B$2.51B63.1712,300
LIVN
LivaNova
2.4911 of 5 stars
$52.33
-2.1%
$59.71
+14.1%
-2.2%$2.92B$1.25B-13.452,900
WRBY
Warby Parker
1.7858 of 5 stars
$27.69
+0.3%
$24.06
-13.1%
+57.8%$2.90B$771.32M-395.513,780News Coverage
Positive News
Analyst Forecast
INSP
Inspire Medical Systems
4.842 of 5 stars
$75.46
-2.3%
$154.43
+104.6%
-64.5%$2.28B$802.80M43.621,246
EYE
National Vision
2.3556 of 5 stars
$29.24
+2.5%
$24.73
-15.4%
+166.3%$2.26B$1.82B-162.4413,411Positive News
PRCT
PROCEPT BioRobotics
3.3884 of 5 stars
$36.49
-0.5%
$70.00
+91.8%
-51.5%$2.04B$274.95M-23.54430
AORT
Artivion
3.1098 of 5 stars
$42.03
+2.4%
$43.13
+2.6%
+54.3%$1.94B$388.54M-100.061,600

Related Companies and Tools


This page (NASDAQ:BLFS) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners